國立虎尾科技大學 |

Hormone related cancer mechanistic and nanomedicines = challenges and prospects /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Hormone related cancer mechanistic and nanomedicines/ edited by Mahfoozur Rahman ... [et al.].
其他題名:	challenges and prospects /
其他作者:	Rahman, Mahfoozur.
出版者:	Singapore :Springer Nature Singapore : : 2022.,
面頁冊數:	xiv, 347 p. :ill., digital ; : 24 cm.;
Contained By:	Springer Nature eBook
標題:	Cancers. -
電子資源:	https://doi.org/10.1007/978-981-19-5558-7
ISBN:	9789811955587

Hormone related cancer mechanistic and nanomedicines = challenges and prospects /
Hormone related cancer mechanistic and nanomedicineschallenges and prospects /[electronic resource] :edited by Mahfoozur Rahman ... [et al.]. - Singapore :Springer Nature Singapore :2022. - xiv, 347 p. :ill., digital ;24 cm.

Chapter 1. Conventional Treatment Approaches in Hormonal Cancer Treatment and Challenges -- Chapter 2. Concept of Nanomedicine in Endocrine Hormone Cancer Treatment -- Chapter 3. Progress of Cancer Nanomedicine, Clinical Hurdles and Opportunities -- Chapter 4. Emergence of Nanohybrids in Hormonal Cancer Targeted Therapy -- Chapter 5. Conventional to Nanoscale-Based Carrier System in Management of Ovarian Cancer -- Chapter 6. Pancreatic Cancer Nanoparticles Targeted Therapy via Epidermal Growth Factor Receptor -- Chapter 7. Nanocarriers Based Targeted Therapies for Pancreatic Cancer and Challenges Ahead -- Chapter 8. Pancreatic Cancer Treatment by Using of Theranostics Nanoparticles -- Chapter 9. Nanomedicine Based Combinational Therapy for Breast Cancer -- Chapter 10. Nano-Liposomal System for Breast Cancer Therapy -- Chapter 11. Conventional to Nanotherapeutic Strategies against Triple-Negative Breast Cancer -- Chapter 12. Effect of Thymoquinone and Its Delivery Through Using of Nanomedicine in Benign Prostatic Hyperplasia -- Chapter 13. Concept of Nanotechnology in Management of Neuroendocrine Tumours -- Chapter 14. Neurocognitive Underpinning of Neurological Disorders: The Role of Default Mode Network -- Chapter 15. Neuroendocrine Carcinoma of The Endometrium: Conventional Treatment Approach to Nanomedicine -- Chapter 16. Effective Luteinizing Hormone Drug Delivery by Gold Nanoparticles in Hormonal Cancer Treatment -- Chapter 17. Regulatory Landscapes in Approval of Cancer Vaccines.

The nanotheranostics sector provides a very promising strategy for monitoring drug biodistribution and pathology longitudinal processes by integrating the imaging and drug delivery functions in one single nanoformulation, providing vital insights into the identification of tumour and predicting the efficacy of nanomedicine. For its unique properties, which include their small size and biocompatibility and ability to permeate the cellular membrane with carrying drugs, nanomaterials have been used for various biomedical applications. This book covers the progress made in hormone-related cancer and their management by nonmedicinal therapy for targeting the hormone regulated cancer with their clinical progress and clinical hurdles.

ISBN: 9789811955587

Standard No.: 10.1007/978-981-19-5558-7doiSubjects--Topical Terms:

1388885
Cancers.

LC Class. No.: RC268.2

Dewey Class. No.: 616.994061

Hormone related cancer mechanistic and nanomedicines = challenges and prospects /
LDR:03260nam a2200325 a 4500 001 1105504
003 DE-He213
005 20230109145406.0
006 m d
007 cr nn 008maaau
008 231013s2022 si s 0 eng d
020 $a 9789811955587 $q (electronic bk.)
020 $a 9789811955570 $q (paper)
024 7 $a 10.1007/978-981-19-5558-7 $2 doi
035 $a 978-981-19-5558-7
040 $a GP $c GP
041 0 $a eng
050 4 $a RC268.2
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.994061 $2 23
090 $a RC268.2 $b .H812 2022
245 0 0 $a Hormone related cancer mechanistic and nanomedicines $h [electronic resource] : $b challenges and prospects / $c edited by Mahfoozur Rahman ... [et al.].
260 $a Singapore : $c 2022. $b Springer Nature Singapore : $b Imprint: Springer,
300 $a xiv, 347 p. : $b ill., digital ; $c 24 cm.
505 0 $a Chapter 1. Conventional Treatment Approaches in Hormonal Cancer Treatment and Challenges -- Chapter 2. Concept of Nanomedicine in Endocrine Hormone Cancer Treatment -- Chapter 3. Progress of Cancer Nanomedicine, Clinical Hurdles and Opportunities -- Chapter 4. Emergence of Nanohybrids in Hormonal Cancer Targeted Therapy -- Chapter 5. Conventional to Nanoscale-Based Carrier System in Management of Ovarian Cancer -- Chapter 6. Pancreatic Cancer Nanoparticles Targeted Therapy via Epidermal Growth Factor Receptor -- Chapter 7. Nanocarriers Based Targeted Therapies for Pancreatic Cancer and Challenges Ahead -- Chapter 8. Pancreatic Cancer Treatment by Using of Theranostics Nanoparticles -- Chapter 9. Nanomedicine Based Combinational Therapy for Breast Cancer -- Chapter 10. Nano-Liposomal System for Breast Cancer Therapy -- Chapter 11. Conventional to Nanotherapeutic Strategies against Triple-Negative Breast Cancer -- Chapter 12. Effect of Thymoquinone and Its Delivery Through Using of Nanomedicine in Benign Prostatic Hyperplasia -- Chapter 13. Concept of Nanotechnology in Management of Neuroendocrine Tumours -- Chapter 14. Neurocognitive Underpinning of Neurological Disorders: The Role of Default Mode Network -- Chapter 15. Neuroendocrine Carcinoma of The Endometrium: Conventional Treatment Approach to Nanomedicine -- Chapter 16. Effective Luteinizing Hormone Drug Delivery by Gold Nanoparticles in Hormonal Cancer Treatment -- Chapter 17. Regulatory Landscapes in Approval of Cancer Vaccines.
520 $a The nanotheranostics sector provides a very promising strategy for monitoring drug biodistribution and pathology longitudinal processes by integrating the imaging and drug delivery functions in one single nanoformulation, providing vital insights into the identification of tumour and predicting the efficacy of nanomedicine. For its unique properties, which include their small size and biocompatibility and ability to permeate the cellular membrane with carrying drugs, nanomaterials have been used for various biomedical applications. This book covers the progress made in hormone-related cancer and their management by nonmedicinal therapy for targeting the hormone regulated cancer with their clinical progress and clinical hurdles.
650 2 4 $a Cancers. $3 1388885
650 2 4 $a Hormone. $3 1389921
650 1 4 $a Oncology. $3 593951
650 0 $a Nanomedicine. $3 590477
650 0 $a Cancer $x Treatment. $3 661325
650 0 $a Cancer $x Endocrine aspects. $3 792353
700 1 $a Rahman, Mahfoozur. $e editor. $3 1324993
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-19-5558-7
950 $a Medicine (SpringerNature-11650)